Sohail Faysal A.
CIK 0001425394 Name as filed on the most recent filing
Filed as Sohail Faysal A. (8)
40 transaction lines · from 8 filings · filed 2013-03-27 to 2018-07-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Menlo Therapeutics Inc. 1 filings
- ISSUER Neos Therapeutics, Inc. 2 filings
- ISSUER Intermolecular Inc 2 filings
- ISSUER Tetraphase Pharmaceuticals Inc 3 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2018-07-24 |
Menlo Therapeutics Inc. MNLO |
S, Open-market sale | 487,500 disposed | 7.65 | 3,729,375.00 | Form 4, filing 0001144204-18-040247 | |
| 2018-07-24 |
Menlo Therapeutics Inc. MNLO |
S, Open-market sale | 12,500 disposed | 7.65 | 95,625.00 | Form 4, filing 0001144204-18-040247 | |
| 2016-04-20 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 8,327 disposed | 9.88 | 82,304.90 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-20 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 213 disposed | 9.88 | 2,105.31 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-19 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 7,097 disposed | 10.03 | 71,175.81 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-19 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 182 disposed | 10.03 | 1,825.28 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-18 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 4,434 disposed | 10.10 | 44,781.63 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-18 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 114 disposed | 10.10 | 1,151.35 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 10,735 disposed | 10.13 | 108,697.24 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 7,020 disposed | 10.32 | 72,429.55 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 275 disposed | 10.13 | 2,784.51 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 180 disposed | 10.32 | 1,857.17 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 13,714 disposed | 10.27 | 140,794.78 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 12,675 disposed | 10.32 | 130,783.18 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 352 disposed | 10.27 | 3,613.81 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 325 disposed | 10.32 | 3,353.42 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-13 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 12,375 disposed | 10.16 | 125,753.51 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-13 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 317 disposed | 10.16 | 3,221.32 | Form 4, filing 0001209191-16-114436 | |
| 2014-11-10 |
Intermolecular Inc IMI |
S, Open-market sale | 4,376,913 disposed | 2.20 | 9,629,208.60 | Form 4, filing 0001209191-14-068129 | |
| 2014-11-10 |
Intermolecular Inc IMI |
S, Open-market sale | 104,342 disposed | 2.20 | 229,552.40 | Form 4, filing 0001209191-14-068129 | |
| 2014-03-20 |
Intermolecular Inc IMI |
S, Open-market sale | 1,800 disposed | 2.86 | 5,154.48 | Form 4, filing 0001012975-14-000433 | |
| 2014-03-19 |
Intermolecular Inc IMI |
S, Open-market sale | 1,800 disposed | 2.83 | 5,100.48 | Form 4, filing 0001012975-14-000433 | |
| 2014-03-18 |
Intermolecular Inc IMI |
S, Open-market sale | 711 disposed | 2.75 | 1,955.25 | Form 4, filing 0001012975-14-000433 | |
| 2014-03-17 |
Intermolecular Inc IMI |
S, Open-market sale | 1,241 disposed | 2.75 | 3,409.65 | Form 4, filing 0001012975-14-000433 | |
| 2014-03-14 |
Intermolecular Inc IMI |
S, Open-market sale | 1,307 disposed | 2.75 | 3,599.09 | Form 4, filing 0001012975-14-000433 | |
| 2014-03-14 |
Intermolecular Inc IMI |
S, Open-market sale | 1,251 disposed | 2.75 | 3,446.25 | Form 4, filing 0001012975-14-000433 | |
| 2014-03-13 |
Intermolecular Inc IMI |
S, Open-market sale | 1,528 disposed | 2.72 | 4,152.95 | Form 4, filing 0001012975-14-000433 | |
| 2013-09-18 |
Tetraphase Pharmaceuticals Inc TTPH |
S, Open-market sale | 97,665 disposed | 10.20 | 996,183.00 | Form 4, filing 0001012975-13-000448 | |
| 2013-09-18 |
Tetraphase Pharmaceuticals Inc TTPH |
S, Open-market sale | 2,335 disposed | 10.20 | 23,817.00 | Form 4, filing 0001012975-13-000448 | |
| 2013-09-17 |
Tetraphase Pharmaceuticals Inc TTPH |
S, Open-market sale | 8,012 disposed | 9.48 | 75,953.76 | Form 4, filing 0001012975-13-000443 | |
| 2013-09-17 |
Tetraphase Pharmaceuticals Inc TTPH |
S, Open-market sale | 192 disposed | 9.48 | 1,820.16 | Form 4, filing 0001012975-13-000443 | |
| 2013-09-16 |
Tetraphase Pharmaceuticals Inc TTPH |
S, Open-market sale | 44,207 disposed | 9.22 | 407,588.54 | Form 4, filing 0001012975-13-000443 | |
| 2013-09-16 |
Tetraphase Pharmaceuticals Inc TTPH |
S, Open-market sale | 1,057 disposed | 9.22 | 9,745.54 | Form 4, filing 0001012975-13-000443 | |
| 2013-09-12 |
Intermolecular Inc IMI |
S, Open-market sale | 3,546 disposed | 5.61 | 19,904.05 | Form 4, filing 0001012975-14-000433 | |
| 2013-07-09 |
Intermolecular Inc IMI |
S, Open-market sale | 400 disposed | 7.34 | 2,935.00 | Form 4, filing 0001012975-14-000433 | |
| 2013-07-05 |
Intermolecular Inc IMI |
S, Open-market sale | 3,146 disposed | 7.42 | 23,351.81 | Form 4, filing 0001012975-14-000433 | |
| 2013-06-14 |
Intermolecular Inc IMI |
S, Open-market sale | 3,546 disposed | 7.28 | 25,817.72 | Form 4, filing 0001012975-14-000433 | |
| 2013-06-14 |
Intermolecular Inc IMI |
S, Open-market sale | 3,546 disposed | 7.25 | 25,717.36 | Form 4, filing 0001012975-14-000433 | |
| 2013-03-25 |
Tetraphase Pharmaceuticals Inc TTPH |
P, Open-market purchase | 628,071 acquired | 7.00 | 4,396,497.00 | Form 4, filing 0001181431-13-019231 | |
| 2013-03-25 |
Tetraphase Pharmaceuticals Inc TTPH |
P, Open-market purchase | 14,786 acquired | 7.00 | 103,502.00 | Form 4, filing 0001181431-13-019231 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Sohail Faysal A., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001425394
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6